Prem Watsa acquired 140 Thousand Xeris Biopharma Holdings shares worth $721 Thousand. That's 0.04% of their equity portfolio (28th largest holding). Prem Watsa started to build up the position in Xeris Biopharma Holdings in Q4 2021 and continued to invest until Q2 2024. Since then they sold 31.3 Thousand shares. The stake costed the investor $299 Thousand, netting the investor a gain of 141% so far.